Parkinson's Disease Tulip


advertisement
 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 06-20-2010, 11:14 PM #1
girija girija is offline
Member
 
Join Date: Nov 2006
Location: southern tip of west coast
Posts: 582
15 yr Member
girija girija is offline
Member
 
Join Date: Nov 2006
Location: southern tip of west coast
Posts: 582
15 yr Member
Default PD objective measurements

Hi all,
This could be a new beginning of evaluating PD. Objective measurements + biomarkers and new therapeutic approaches = hope for a better treatment????
Girija

RFA from the Kinetics Foundation

Help test the value of objective measurements for PD, and receive free equipment and support for your trial or study!

Measurements that are both objective and precise are in critical need in the development of new treatments for Parkinson's Disease, particularly with the evaluation of neuroprotective therapies.

The Kinetics Foundation has supported the development and validation of the OPDM (Objective Parkinson's Disease Measurement) System, consisting of two different input devices and a back-end data server, and is now making these integrated systems available to the research community. The system was developed and validated at Academic Centers including Oregon Health Science University and Portland State University and have been used at a number of supporting institutions including the NIH, UCSF, and Rush University Medical Center; created in part through collaboration with Intel.

Call to Action: While the OPDM system has shown good promise, it is new to the Parkinson's community at large. The Kinetics Foundation has offered to provide free systems, as well as some funds for third party costs of patient participants. Their goal is to accelerate the adoption of objective measurement devices by providing the OPDM System to studies and trials that would benefit from features like increased precision and more frequent measurements.

Systems are limited, so those wishing to receive them must submit a brief online application, explaining how their study would benefit from using the system, and agree to publicly share the results they obtain from the use of the devices (e.g. journal publication, pdonlineresearch.org).

The OPDM-Dexterity can be used in clinic and/or at home, the OPDM-Mobility is clinic-only; any proposed combination of devices and locations will be considered.

We will have representatives at the MDS Congress in Buenos Aries; for more information, including how to apply, contact OPDM@kineticsfoundation.org. Please include information regarding your trial, including the number of subjects you would like to test. More information will be made available online by July 1, 2010. Submissions will be due by August 1, 2010. Winners of these systems, and the financial support that accompanies them, will be announced by September 1, 2010.
girija is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
Conductor71 (06-21-2010), rd42 (06-21-2010)
 


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
Seeking objective info, all the way from Brazil Flavio Reflex Sympathetic Dystrophy (RSD and CRPS) 8 09-30-2007 10:27 AM


All times are GMT -5. The time now is 07:44 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.